• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

IIT Principal Investigator Laura Cancedda Elected as New Member of EMBO

Bioengineer by Bioengineer
September 6, 2025
in Biology
Reading Time: 4 mins read
0
Laura Cancedda
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a significant stride for the European life sciences community, Laura Cancedda, head of the Brain Development and Disease Research Unit at the Italian Institute of Technology (Istituto Italiano di Tecnologia – IIT) in Genoa, Italy, has been elected as a member of the prestigious European Molecular Biology Organization (EMBO). This election recognizes her outstanding contributions to neuroscience and developmental biology, further establishing her as a leading figure in brain research. EMBO, renowned for comprising over 2,100 distinguished scientists across Europe and beyond, acknowledges Cancedda’s groundbreaking investigations into neural development and disorders, marking a high honor in her esteemed career.

EMBO’s 2025 cohort features 60 newly elected members representing diverse disciplines ranging from RNA biology and epidemiology to molecular medicine and plant sciences, demonstrating the expansive scope of modern life sciences. What distinguishes this year’s selection is the limited representation from Italy; among the two scientists currently leading research in Italian institutions, Laura Cancedda stands prominently. This highlights the increasing visibility of Italian neuroscience within the broader European research ecosystem, amplified by Cancedda’s exemplary work merging molecular techniques with translational applications.

Membership within EMBO goes beyond recognition; it is an active engagement with the future of life sciences. Members play critical roles by influencing EMBO’s strategic direction through council participation, serving on editorial boards of top-tier scientific journals, and reviewing competitive funding applications. These responsibilities ensure that EMBO remains at the forefront of emerging scientific trends and fosters international collaboration. The rigorous nomination and peer-elected process emphasize the organization’s commitment to excellence and diversity across scientific disciplines.

.adsslot_NdqUxQyF1s{ width:728px !important; height:90px !important; }
@media (max-width:1199px) { .adsslot_NdqUxQyF1s{ width:468px !important; height:60px !important; } }
@media (max-width:767px) { .adsslot_NdqUxQyF1s{ width:320px !important; height:50px !important; } }

ADVERTISEMENT

Fiona Watt, EMBO’s Director, emphasized the vitality of new members by stating, “Science thrives on global collaboration, and the annual election of the new EMBO Members brings fresh energy and inspiration to our community.” This reflects EMBO’s vision of uniting researchers who not only have made substantial scientific advances but also aspire to push the boundaries of life sciences through cooperative efforts. Cancedda’s inclusion promises to infuse valuable insights from her neuroscience expertise, particularly her efforts to decode complex neurodevelopmental disorders.

The formal induction of the 2025 EMBO cohort is set to take place at the upcoming EMBO Members’ Meeting in Heidelberg, Germany, a pivotal event fostering dialogue and collaboration among Europe’s science elite. This gathering provides a platform for members to share cutting-edge research findings and catalyze interdisciplinary partnerships. Membership directories, accessible online, catalog the affiliations and research specialties of all EMBO scientists, facilitating global networking opportunities and knowledge exchange.

Laura Cancedda’s journey exemplifies a robust integration of academic rigor and innovative translational research. After earning her degree in Pharmaceutical Chemistry and Technology from the University of Genoa, she pursued a PhD in Neurophysiology at the Scuola Normale Superiore in Pisa. Her postdoctoral work at the University of California, Berkeley, further augmented her expertise, enabling her to bridge molecular neuroscience with clinical relevance. Since returning to Italy, she has led IIT’s Brain Development and Disease unit, focusing on neurodevelopmental anomalies that underlie disorders such as Down syndrome and autism spectrum conditions.

Beyond her academic pursuits, Cancedda co-founded IAMA Therapeutics, a biotech start-up devoted to developing neuroscience-based pharmacological interventions, particularly targeting autism spectrum disorders. This entrepreneurial endeavor exemplifies her commitment to translating laboratory discoveries into novel therapies, addressing urgent unmet medical needs and enhancing patient outcomes. Her work underscores an integrative approach, combining molecular neuroscience, pharmacology, and clinical application.

Over the years, Cancedda’s contributions have been recognized by numerous awards, reflecting her standing in the global neuroscience community. In 2025, she received the FIS2 Advanced Investigator Award from the Italian Science Fund, acknowledging her innovative research leadership. Her earlier accolades include the Telethon Career Award in 2016 for her editorial and experimental achievements in Down syndrome and the prestigious ERC Consolidator Grant, which supported her cutting-edge projects investigating brain development and neuroplasticity mechanisms.

Her dedication to advancing neuroscience is further evidenced by her membership in elite networks such as the FENS-KAVLI Network of Excellence, fostering collaboration across Europe’s leading brain researchers. In 2009, she garnered the Young Investigator Award from the Italian Society of Physiology, marking early recognition that presaged her continuing scientific impact. These honors collectively highlight her influence across basic and applied neuroscience domains.

Cancedda’s research meticulously unravels the cellular and molecular pathways governing neurodevelopmental disorders, placing particular emphasis on the interplay between synaptic function and neural circuit formation. Her laboratory employs a range of innovative methodologies, including in vivo imaging, electrophysiology, and molecular profiling, to interrogate how mutations and environmental factors disrupt brain maturation. The goal is to identify actionable molecular targets that can be modulated pharmacologically to restore typical neural function, an endeavor that holds great promise for neurodevelopmental therapeutics.

The election to EMBO is not merely a personal achievement but a testament to the vibrant scientific culture cultivated at IIT and across Italy. Cancedda’s recognition illustrates the increasing role of Italian researchers in pioneering advances that resonate on the European and global stages. By joining EMBO’s ranks, she will contribute to guiding research agendas and mentoring the next generation of scientists, fostering an environment of excellence and innovation critical for addressing complex neurological diseases.

In sum, Laura Cancedda’s election to EMBO exemplifies the convergence of scientific excellence, clinical relevance, and collaborative spirit essential for modern life sciences. Her work, spanning fundamental neuroscience to translational medicine, continues to illuminate the mechanisms of brain development and disorder, putting forward novel avenues for therapeutic intervention. As EMBO welcomes her into its community, the broader neuroscience field can anticipate exciting advancements fueled by her expertise and visionary leadership.

Subject of Research: Brain Development and Neurodevelopmental Disorders, Neural Plasticity, Neuropharmacology, Down Syndrome, Autism Spectrum Disorders

Article Title: Leading Neuroscientist Laura Cancedda Elected to EMBO for Pioneering Brain Development Research

News Publication Date: July 1, 2025

Web References:

EMBO Membership Directory: https://people.embo.org/
Italian Institute of Technology: https://iit.it

Image Credits: Credit: IIT – Istituto Italiano di Tecnologia

Keywords: Life sciences, Scientific community, Scientific organizations, Neuroscience, Developmental neuroscience

Tags: brain development and disordersdevelopmental biology researchEMBO membership announcementEuropean Molecular Biology OrganizationEuropean research ecosystemIIT Principal InvestigatorItalian Institute of TechnologyItalian neuroscience visibilityLaura Canceddalife sciences communitymolecular techniques in researchneuroscience contributionstranslational applications in science

Share12Tweet8Share2ShareShareShare2

Related Posts

N6-methyladenosine Enhances Pork Muscle Quality via Myofiber Regulation

N6-methyladenosine Enhances Pork Muscle Quality via Myofiber Regulation

October 6, 2025
blank

Whole Genome Analysis Uncovers Variations in Goat Pigmentation

October 5, 2025

LINC01547 Enhances Pancreatic Cancer and Chemoresistance

October 5, 2025

MeaB bZIP Factor Essential for Nitrosative Stress Response

October 5, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    94 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    92 shares
    Share 37 Tweet 23
  • New Insights Suggest ALS May Be an Autoimmune Disease

    71 shares
    Share 28 Tweet 18
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

N6-methyladenosine Enhances Pork Muscle Quality via Myofiber Regulation

Designing Thiadiazole β-Carboline Derivatives as Glucosidase Inhibitors

Mycoplasma Pneumoniae Linked to Neuromyelitis Optica Case

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.